Results 101 to 110 of about 46,480 (151)

A New Risk Score Based on Machine Learning in Patients with Acute Heart Failure: The ML-HF score. [PDF]

Arq Bras Cardiol
Ferreira MBD, Daikubara Neto JT, Cunha GSPD, Moretti R, Reichert JT, Prado LM, Cirino RHD, Smith SC, Taniguchi FP, Sposito AC, Silvestre OM, Nadruz W, Fernandes-Silva MM.   +12 more
europepmc   +1 more source

Apical Sparing and Granular Sparkling: Not Everything that Glitters Is Cardiac Amyloidosis. [PDF]

Arq Bras Cardiol
Barros APM, Romero CE, Cardoso JN, Fernandes F, Hotta VT.   +4 more
europepmc   +1 more source

Clinical Outcomes and Mortality in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention. [PDF]

Arq Bras Cardiol
Başkurt AA, Güneri S, Yılancıoğlu RY, Turan OE, Özcan EE.   +4 more
europepmc   +1 more source

Long-term mortality and predictive score performance in Brazilian atherosclerotic renovascular disease patients. [PDF]

J Bras Nefrol
Salome JG, Moraes LP, Hagemann R, Silva VDS, Carvalho FC, Franco RJDS, Vassallo D, Martin LC, Kalra PA, Barretti P.   +9 more
europepmc   +1 more source

“ASOCIACIÓN DE LA FUNCIÓN RENAL Y LOS CAMBIOS ECOGRÁFICOS DEL INJERTO RENAL EN PACIENTES DE 17 A 40 AÑOS TRASPLANTADOS EN EL CENTRO MÉDICO LIC. ADOLFO LÓPEZ MATEOS DE JULIO A NOVIEMBRE 2012” [PDF]

, 2013
Romero Martínez, Carlos, Villagrán Nicasio, Griselda   +1 more
core  

Reversal of Left Bundle Branch Block Following Treatment in Alcoholic Cardiomyopathy. [PDF]

Arq Bras Cardiol
Barroso MCRD, Madogolele HDCN, Belfort DSP, Biselli B, Ayub-Ferreira SM, Bocchi EA.   +5 more
europepmc   +1 more source

Improvement in kidney function in patients with chronic hepatitis B and chronic kidney disease after switching to tenofovir alafenamide fumarate: a systematic review with single arm meta-analysis. [PDF]

J Bras Nefrol
Pascoa Junior JG, Huntermann R, Gomes VMV, Mendes Filho FSM, Bertozzi JMV, Lins PRG.   +5 more
europepmc   +1 more source

[Incidence, associated comorbidity, and risk factors for severe exacerbation of chronic obstructive pulmonary disease: A retrospective cohort study 2021-2022]. [PDF]

Aten Primaria
Montserrat-Capdevila J, Vaqué Castilla P, Gea-Sánchez M, Olivares-Sanzo P.   +3 more
europepmc   +1 more source

Gepants: Key Features of A Potent Therapeutic Option and Considerations in The Latin American Context. [PDF]

Rev Neurol
Patiño DR, Zapata JC, Aguirre ALV.
europepmc   +1 more source

Papel del laboratorio clínico en el estudio de nefrolitiasis y cristaluria por mesalazina. [PDF]

Adv Lab Med
Balbuena AI, Poveda N, López A, Ferri MJ.   +3 more
europepmc   +1 more source